thiazoles has been researched along with Nycturia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Delfino, K; Dynda, D; El-Zawahry, A; McVary, KT; Petrossian, RA | 1 |
| Gibson, W; Makhani, A; Thake, M | 1 |
| Abreu-Mendes, P; Cruz, F; Martins-Silva, C | 1 |
| Furuhata, M; Hosaka, K; Ishizuka, O; Minagawa, T; Nakagawa, T; Ogawa, T; Saito, T; Suzuki, T | 1 |
| Hodgkinson, L | 1 |
| Chapple, C; Gacci, M; Gravas, S; Kaplan, SA; McVary, KT; Moncada, I; Morgia, G; Russo, GI; Sebastianelli, A; Serni, S | 1 |
| Amarenco, G; Chapple, CR; Everaert, K; Liehne, J; López Aramburu, MA; Lucas, M; Ridder, A; Snijder, R; Vik, V; Yamaguchi, O | 1 |
| Dmochowski, R; Kaufman, M; Osborn, D; Reynolds, WS; Suarez, O | 1 |
| Arber, M; Fleetwood, K; Freemantle, N; Ginsberg, DA; Glanville, J; Khalaf, K; Loveman, C; McCool, R; Ni, Q | 1 |
4 review(s) available for thiazoles and Nycturia
| Article | Year |
|---|---|
Mirabegron in the Treatment of Overactive Bladder: Safety and Efficacy in the Very Elderly Patient.
Topics: Acetanilides; Age Factors; Aged; Aged, 80 and over; Female; Humans; Lower Urinary Tract Symptoms; Nocturia; Patient Safety; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urological Agents | 2020 |
Treatment of neurogenic lower urinary tract symptoms: main contributions from 2018 and 2019.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Botulinum Toxins, Type A; Humans; Lower Urinary Tract Symptoms; Muscarinic Antagonists; Nocturia; Thiazoles; Urinary Bladder, Neurogenic; Urological Agents | 2020 |
Systematic review and meta-analysis on the efficacy and tolerability of mirabegron for the treatment of storage lower urinary tract symptoms/overactive bladder: Comparison with placebo and tolterodine.
Topics: Acetanilides; Humans; Lower Urinary Tract Symptoms; Nocturia; Randomized Controlled Trials as Topic; Thiazoles; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents | 2018 |
Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder: an indirect treatment comparison.
Topics: Acetanilides; Botulinum Toxins, Type A; Humans; Nocturia; Thiazoles; Urinary Bladder, Overactive; Urinary Incontinence; Urination; Urological Agents | 2016 |
2 trial(s) available for thiazoles and Nycturia
| Article | Year |
|---|---|
Effect of oxybutynin patch versus mirabegron on nocturia-related quality of life in female overactive bladder patients: A multicenter randomized trial.
Topics: Acetanilides; Double-Blind Method; Female; Humans; Mandelic Acids; Nocturia; Quality of Life; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive | 2021 |
A proof-of-concept study: mirabegron, a new therapy for overactive bladder.
Topics: Acetanilides; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Nocturia; Quality of Life; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urination; Urological Agents | 2013 |
3 other study(ies) available for thiazoles and Nycturia
| Article | Year |
|---|---|
Mirabegron improves sleep measures, nocturia, and lower urinary tract symptoms in those with urinary symptoms associated with disordered sleep.
Topics: Acetanilides; Aged; Female; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Nocturia; Prospective Studies; Sleep; Sleep Wake Disorders; Thiazoles; Treatment Outcome | 2020 |
American Urological Association (AUA) - 112th Annual Meeting (May 12-16, 2017 - Boston, Massachusetts, USA).
Topics: Acetanilides; Administration, Intranasal; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Clinical Trials, Phase III as Topic; Deamino Arginine Vasopressin; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Humans; Hydrogels; Mitomycin; Multicenter Studies as Topic; Nocturia; Randomized Controlled Trials as Topic; Solifenacin Succinate; Thiazoles; United States; Urinary Bladder Neoplasms; Urinary Bladder, Overactive; Urology | 2017 |
Mirabegron for male lower urinary tract symptoms.
Topics: 5-alpha Reductase Inhibitors; Acetanilides; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-3 Receptor Agonists; Humans; Lower Urinary Tract Symptoms; Male; Nocturia; Prostatic Hyperplasia; Prostatism; Thiazoles; Urinary Bladder, Overactive; Urological Agents | 2013 |